Evidence map›Paper›PMID 34988031›Full record

ArticleFrontiers in oncology2021

Corrigendum: Everything Old Is New Again: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway.

Anisha S Jain, Ashwini Prasad, Sushma Pradeep, Chandan Dharmashekar, Raghu Ram Achar, Ekaterina Silina, Victor Stupin, Raghavendra G Amachawadi, Shashanka K Prasad, R Pruthvish and 3 more

Abstract readPublished Erratum
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Diethyldithiocarbamate-CuNanomedicine (London, England) · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Anisha S JainDepartment of Microbiology, School of Life Sciences, JSS Academy of Higher Education and Research, Mysuru, India.
Ashwini PrasadDepartment of Microbiology, School of Life Sciences, JSS Academy of Higher Education and Research, Mysuru, India.
Sushma PradeepDepartment of Biotechnology and Bioinformatics, School of Life Sciences, JSS Academy of Higher Education and Research, Mysuru, India.
Chandan DharmashekarDepartment of Biotechnology and Bioinformatics, School of Life Sciences, JSS Academy of Higher Education and Research, Mysuru, India.
Raghu Ram AcharDivision of Biochemistry, School of Life Sciences, JSS Academy of Higher Education and Research, Mysuru, India.
Ekaterina SilinaDepartment of Human Pathology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Victor StupinDepartment of Hospital Surgery, N.I. Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia.
Raghavendra G AmachawadiDepartment of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS, United States.
Shashanka K PrasadDepartment of Biotechnology and Bioinformatics, School of Life Sciences, JSS Academy of Higher Education and Research, Mysuru, India.
R PruthvishDepartment of Biotechnology, Acharya Institute of Technology, Bengaluru, India.
Asad SyedDepartment of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Chandan ShivamalluDepartment of Biotechnology and Bioinformatics, School of Life Sciences, JSS Academy of Higher Education and Research, Mysuru, India.
Shiva Prasad KollurDepartment of Sciences, Amrita School of Arts and Sciences, Amrita Vishwa Vidyapeetham, Mysuru, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2021.741326.].

Indexed as

drug repurposing/repositioninginhibitorsMAPKnon-small cell lung cancertargeted therapy

Identifiers

PMID34988031
PMCPMC8722216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.